Daratumumab plus bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.

Affiliation auteurs!!!! Error affiliation !!!!
TitreDaratumumab plus bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA.
Type de publicationJournal Article
Year of Publication2020
AuteursTouzeau C, Moreau P, Perrot A, Hulin C, Dib M, Tiab M, Caillot D, Facon T, Leleu X, van de Donk NWCJ, Broijl A, Zweegman S, Levin M-D, Delforge M, Pei L, Vanquickelberghe V, de Boer C, Kampfenkel T, Vermeulen J, Sonneveld P, IFM, HOVON
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X